Related Experiment Video
Updated: May 6, 2026
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
A structure-differential binding method for elucidating the interactions between flavonoids and cytochrome-c by
Xian Wang1, Yingzhi Liu, Haidong Wang
1Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, College of Chemistry and Materials Science, South-Central University for Nationalities, Wuhan, Hubei 430074, People's Republic of China.
A new Structure-Differential Binding-Electrospray Ionization Mass Spectrometry-Molecular Docking (SDB-ESI-MS-MD) method characterizes drug-protein binding sites and mechanisms. This approach enhances understanding of noncovalent interactions for therapeutic design.
Area of Science:
- Biochemistry and Structural Biology
- Pharmacology and Drug Discovery
- Computational Chemistry
Background:
- Noncovalent interactions between pharmaceuticals and proteins are crucial for drug development and understanding protein function.
- Electrospray ionization mass spectrometry (ESI-MS) is widely used for analyzing noncovalent protein complexes but often struggles to pinpoint interaction sites and mechanisms.
- Accurate characterization of binding sites and modes is essential for rational drug design and optimizing therapeutic efficacy.
Purpose of the Study:
- To develop and validate a novel Structure-Differential Binding-Electrospray Ionization Mass Spectrometry-Molecular Docking (SDB-ESI-MS-MD) method.
- To characterize the binding sites and modes of interaction between flavonoid ligands and cytochrome-c (Cyt-c).
- To demonstrate the applicability of the SDB-ESI-MS-MD method for a broad range of protein-drug interactions.
Main Methods:
- Integration of Structure-Differential Binding (SDB) with ESI-MS and Molecular Docking (MD) techniques.
- ESI-MS was employed to quantify relative binding affinities, dissociation constants, and assess complex stability changes.
- Molecular docking simulations were utilized to visualize and analyze protein-ligand interaction profiles and binding modes.
Main Results:
- The SDB-ESI-MS-MD method successfully characterized binding sites and modes for flavonoid-Cyt-c complexes.
- ESI-MS data provided insights into the influence of ligand structural modifications on binding affinity and protein complex stability.
- Molecular docking simulations corroborated ESI-MS findings, offering detailed atomic-level interaction information.
Conclusions:
- The developed SDB-ESI-MS-MD method offers a powerful approach for characterizing protein-drug interactions, including binding sites and modes.
- This integrated technique enhances the study of structure-binding relationships between small molecules and biomacromolecules.
- The method provides valuable guidance for de novo therapeutic agent design and further research in drug discovery.
